[2026] NSWCATAP 55
General information, not legal advice.
NCAT Appeal Panel
2026-02-26
Seiden SC DCJ, Deputy PresidentP H Molony, Senior Member
Original judgment source is linked above.
AFC v Sydney Children's Hospital Speciality Network [2012] NSWADT 189
AIN v Medical Council of New South Wales [2017] NSWCATAP 23
Brazel v Sydney Water Corporation [2026] NSWCATAP 9.
BZE v NSW Public Guardian [2015] NSWCATAP 64
Chalik v Chalik [2025] NSWCA 136
Clyne v Deputy Commissioner of Taxation (1981) 150 CLR 1; [1981] HCA 40
Collection House Limited v Taylor [2004] VSC 49
Collins v Urban [2014] NSWCATAP 17
Commissioner of Police, New South Wales Police Force v Parish [2025] NSWCATAP 180
Commissioner of Police, NSW Police Force v FYH [2024] NSWCATAP 176
Conservation Council of WA Inc v The Hon Stephen Dawson MLC, Minister for Environment; Disability Services [2019] WASCA 102; (2019) 240 LGERA 387
Craig v State of South Australia (1995) 184 CLR 163; [1995] HCA 58
Craig Williamson Pty Ltd v Barraclough [1915] VicLawRp 66; [1915] VLR 450
Davenport v The Owners - Strata Plan 536; The Owners - Strata Plan 536 v Davenport [2018] NSWCATAP 301
Department of Education and Communities v VK (GD) [2011] NSWADTAP 61
Ferella & Anor v Chief Commissioner of State Revenue [2014] NSWCA 378
FZK v Department of Customer Service [2024] NSWCATAP 185
FZP v Sydney Children's Hospitals Network [2025] NSWCATAD 144
Ghali v Commissioner of State Revenue [2013] NSWCA 340; (2013) 85 NSWLR 378
GPT re ltd v Belmorgan Property Development Ptd Ltd (2008) 72 NSWLR 647; [2008] NSWCA 256
Hamod v New South Wales [2011] NSWCA 375
Hannaford v Commonwealth Bank of Australia [2014] NSWCA 297
Haritos v Federal Commissioner of Taxation (2015) 233 FCR 315; [2015] FCAFC 92
Hill v Woollahra Municipal Council & Ors [2003] NSWCA 106
Hogan v Hinch (2011) 243 CLR 506; [2011] HCA 4
House v The King (1936) 55 CLR 499; [1936] HCA 40
Jurecek v Director, Transport Safety Victoria [2016] VSC 285
Kocic v Commissioner of Police, NSW Police Force (GD) [2013] NSWADTAP 53
Kudrynski v Orange City Council [2024] NSWCA 33
M H Investments Aust Pty Ltd v Hurstville City Council [2015] NSWCATAP 180
McKinnon v Secretary, Department of Treasury [2006] HCA 45
Minister for Immigration and Border Protection v SZMTA (2019) 264 CLR 421; [2019] HCA 3
Minister for Immigration and Multicultural Affairs v Yusuf (2001) 206 CLR 323; [2001] HCA 30
Minister for Natural Resources v New South Wales Aboriginal Land Council(1987) 9 NSWLR 154
Nathanson v Minister for Home Affairs (2022) 276 CLR 80; [2022] HCA 26
New South Wales v Wojciechowska [2025] HCA 27
Orr v Cobar Management Pty Ltd (2020) 103 NSWLR 36; [2020] NSWCCA 220
O'Sullivan v Farrer (1989) 168 CLR 210; [1989] HCA 61
Perry Properties Pty Ltd v Chief Commissioner of State Revenue (2013) 85 NSWLR 240; [2013] NSWCA 274
R v Brown [1996] AC 543
Re Minister for Resources; Ex Parte Cazaly Iron Pty Ltd [2007] WASCA 175
Schwartz Family Co Pty Ltd v Capitol Carpets Pty Ltd [2017] NSWCA 223
Secretary, Department of Family and Community Services v Smith [2017] NSWCA 206; (2017) 95 NSWLR 597
Smoker v Pharmacy Restructuring Authority [1994] FCA 1487; (1994) 53 FCR 287
Thomas and Naaz Pty Ltd v Chief Commissioner of State Revenue [2023] NSWCA 40
Unique Commercial Group Pty Ltd [2024] NSWCATAP 204
Warren v Coombes (1979) 142 CLR 531; [1979] HCA 9
IPC, Statutory Guidelines on Research, Health Records and Information Privacy Act 2002 (NSW)
New South Wales, Parliamentary Debates, Legislative Council, 11 June 2002
(1) Pursuant to s 64(1)(a) of the Civil and Administrative Tribunal Act 2013 (NSW), publication or broadcast of the name of the Appellant is prohibited.
Note: A reference to the name of a person includes a reference to any information, picture or other material that identifies the person or is likely to lead to the identification of the person.
(1) That the SCHN had breached HPP 5(1)(c) (HRIP Act, Sch 1) with respect to the protection and security of FZP's information.
(2) That there was a disclosure by SCHN of FZP's identifiable health information to MRCI.
(3) That the disclosure did not breach HPP 11 (HRIP Act, Sch 1) because it was for the secondary purpose of research, and satisfied the requirements of HPP 11(1)(f).
(4) That there was no separate use of FZP's information by the SCHN apart from the disclosure. As a consequence, the use principle in HPP 10 (HRIP Act, Sch 1) did not need to be considered.
...
(2) The Respondent is to provide an unreserved formal written apology to the Applicant addressing and apologising for the Respondent's breach of HPP 5(1)(c) in respect of the Applicant's health information and for all distress caused to the Applicant as a result of that breach.
(3) The Respondent is to pay the Applicant $6,000 in damages for the above breach.
(4) Orders 2 and 3 are to be complied with within 30 days of the date of these orders.
(5) The Respondent, as soon as practicable, must review, update and monitor its procedures so that disclosures of health information for research purposes without consent:
(a) comply with approved security protocols for the method of sending identifiable health information;
(b) clearly reference the research project and applicable waiver of consent; and
(c) include warnings as to confidentiality and limitations on use.
3 Purpose and objects of Act
(1) The purpose of this Act is to promote fair and responsible handling of health information by -
(a) protecting the privacy of an individual's health information that is held in the public and private sectors, and
(b) enabling individuals to gain access to their health information, and
(c) providing an accessible framework for the resolution of complaints regarding the handling of health information.
(a) to balance the public interest in protecting the privacy of health information with the public interest in the legitimate use of that information, and
(b) to enhance the ability of individuals to be informed about their health care, and
(c) to promote the provision of quality health services.
5 Definition of "personal information"
(1) In this Act, personal information means information or an opinion (including information or an opinion forming part of a database and whether or not recorded in a material form) about an individual whose identity is apparent or can reasonably be ascertained from the information or opinion.
(2) Personal information includes such things as an individual's fingerprints, retina prints, body samples or genetic characteristics.
6 Definition of "health information"
In this Act, health information means -
(a) personal information that is information or an opinion about -
(i) the physical or mental health or a disability (at any time) of an individual, or
(ii) an individual's express wishes about the future provision of health services to him or her, or
(iii) a health service provided, or to be provided, to an individual, or
(b) other personal information collected to provide, or in providing, a health service, or
(c) other personal information about an individual collected in connection with the donation, or intended donation, of an individual's body parts, organs or body substances, or
(d) other personal information that is genetic information about an individual arising from a health service provided to the individual in a form that is or could be predictive of the health (at any time) of the individual or of a genetic relative of the individual, or
(e) healthcare identifiers,
but does not include health information, or a class of health information or health information contained in a class of documents, that is prescribed as exempt health information for the purposes of this Act generally or for the purposes of specified provisions of this Act.
11 How this Act applies to organisations
(1) This Act applies to every organisation that is a health service provider or that collects, holds or uses health information.
Note.
The term organisation means a public sector agency or a private sector person.
(2) An organisation to whom or to which this Act applies is required to comply with the Health Privacy Principles and with any health privacy code of practice or provision of Part 4 that is applicable to the organisation.
(3) An organisation must not do any thing, or engage in any practice, which contravenes a Health Privacy Principle or a health privacy code of practice or a provision of Part 4 in respect of which the organisation is required to comply.
...
64 Guidelines by Privacy Commissioner
(1) The Privacy Commissioner may issue guidelines for or with respect to any matter for which guidelines may be issued under this Act. The Privacy Commissioner may from time to time amend or replace the guidelines.
(2) Guidelines issued by the Privacy Commissioner may apply, adopt or incorporate any publication as in force for the time being.
(3) The Minister may request the Privacy Commissioner to develop guidelines relating to any matter that the Minister considers should be the subject of guidelines.
(4) The procedure for the issuing of guidelines is as follows -
(a) the Privacy Commissioner is to prepare proposed guidelines in draft form and is to prepare an impact assessment statement for the proposed guidelines in accordance with such requirements as the Minister may from time to time determine,
(b) the draft guidelines and impact assessment statement are to be publicly exhibited for a period of at least 21 days,
(c) the Privacy Commissioner is to seek public comment on the draft guidelines during the period of public exhibition and public comment may be made during the period of the exhibition and for 21 days (or such longer period as the Privacy Commissioner may determine) after the end of that period,
(d) the Privacy Commissioner is to submit the draft guidelines to the Minister for approval together with a report by the Privacy Commissioner giving details of public comment received during the period allowed for public comment and the Privacy Commissioner's response to it,
(e) the Privacy Commissioner is not to issue the draft guidelines as guidelines unless the Minister approves the guidelines.
(5) The procedure for the amendment or replacement of guidelines is the same as for the issuing of the guidelines unless the Minister otherwise directs in respect of a particular amendment.
Schedule 1 Health Privacy Principles
...
10 Limits on use of health information
(1) An organisation that holds health information must not use the information for a purpose (a secondary purpose) other than the purpose (the primary purpose) for which it was collected unless -
...
(f) Research
the use of the information for the secondary purpose is reasonably necessary for research, or the compilation or analysis of statistics, in the public interest and -
(A) that purpose cannot be served by the use of information that does not identify the individual or from which the individual's identity cannot reasonably be ascertained and it is impracticable for the organisation to seek the consent of the individual for the use, or
(B) reasonable steps are taken to de-identify the information, and
(ii) if the information could reasonably be expected to identify individuals, the information is not published in a generally available publication, and
(iii) the use of the information is in accordance with guidelines, if any, issued by the Privacy Commissioner for the purposes of this paragraph, or
...
11 Limits on disclosure of health information
(1) An organisation that holds health information must not disclose the information for a purpose (a secondary purpose) other than the purpose (the primary purpose) for which it was collected unless -
...
(f) Research
the disclosure of the information for the secondary purpose is reasonably necessary for research, or the compilation or analysis of statistics, in the public interest and -
(A) that purpose cannot be served by the disclosure of information that does not identify the individual or from which the individual's identity cannot reasonably be ascertained and it is impracticable for the organisation to seek the consent of the individual for the disclosure, or
(B) reasonable steps are taken to de-identify the information, and
(ii) the information will not be published in a form that identifies particular individuals or from which an individual's identity can reasonably be ascertained, and
(iii) the disclosure of the information is in accordance with guidelines, if any, issued by the Privacy Commissioner for the purposes of this paragraph, or
...
14 Transborder data flows and data flow to Commonwealth agencies
An organisation must not transfer health information about an individual to any person or body who is in a jurisdiction outside New South Wales or to a Commonwealth agency unless -
(a) the organisation reasonably believes that the recipient of the information is subject to a law, binding scheme or contract that effectively upholds principles for fair handling of the information that are substantially similar to the Health Privacy Principles, or
(b) the individual consents to the transfer, or
(c) the transfer is necessary for the performance of a contract between the individual and the organisation, or for the implementation of pre-contractual measures taken in response to the individual's request, or
...
(g) the organisation has taken reasonable steps to ensure that the information that it has transferred will not be held, used or disclosed by the recipient of the information inconsistently with the Health Privacy Principles, or
(h) the transfer is permitted or required by an Act (including an Act of the Commonwealth) or any other law.
...
55 Administrative review of conduct by Tribunal
...
(2) On reviewing the conduct of the public sector agency concerned, the Tribunal may decide not to take any action on the matter, or it may make any one or more of the following orders -
(a) subject to subsections (4) and (4A), an order requiring the public sector agency to pay to the applicant damages not exceeding $40,000 by way of compensation for any loss or damage suffered because of the conduct,
(b) an order requiring the public sector agency to refrain from any conduct or action in contravention of an information protection principle or a privacy code of practice,
(c) an order requiring the performance of an information protection principle or a privacy code of practice,
(d) an order requiring personal information that has been disclosed to be corrected by the public sector agency,
(e) an order requiring the public sector agency to take specified steps to remedy any loss or damage suffered by the applicant,
(f) an order requiring the public sector agency not to disclose personal information contained in a public register,
(g) such ancillary orders as the Tribunal thinks appropriate.
80 Making of internal appeals
...
(2) Any internal appeal may be made:
(a) in the case of an interlocutory decision of the Tribunal at first instance - with the leave of the Appeal Panel, and
(b) in the case of any other kind of decision (including an ancillary decision) of the Tribunal at first instance - as of right on any question of law, or with the leave of the Appeal Panel, on any other grounds.
"Those questions of law should be, in our opinion, what are sometimes described as 'pure questions of law.' They should not draw the Court of Criminal Appeal into questions of fact. Moreover, they must be questions whose character as a question of law can be recognised on the face of the question, and not depend upon the answer given to the question. This does not include a question which may ultimately disclose an error of law depending on an analysis of the facts but where this cannot be known without scrutiny of the facts..."
"29 The Research Project was described as follows:
'This study will examine the feasibility and value of genomic testing in clinical practice, along with providing research pathways for further investigation of undiagnosed cases.'
30 The Research Project included disease 'flagships', broadly defined as Rare Disease and Cancer. Within those flagships there were a number of projects focussed on particular conditions. One of those was 'Clinical Flagship: Mitochondrial Diseases'.
31 The Protocol for the Research Project, at Section 4.5 of the Study Protocol (with wording consistent in the various versions):
(1) included a retrospective review of a secondary cohort population (i.e. not current patients in the 'main' study population), for which historical data existing on hospital or laboratory records could be collected without consent (my emphasis in italics below):
'... The data will ... provide sound baseline comparator data to assess the additional diagnostic yield and clinical utility of genomic testing in different disease areas.
...
'Participant group: The cohort of patients will have been assessed for diagnostic purposes either as inpatients or outpatients at the hospitals covered by the current multi-site research ethics Protocol or have had genetic testing through laboratory diagnostic services associated with the study. This retrospective review will capture data from patients presenting during the study period, 1st January 2016 through to December 2020, or the end of the study. Data will be collected for a maximum of 550 paediatric and adult patients per flagship.
Recruitment and consent: Consent will not be sought for this retrospective review of patient records. All collected data will be de-identified and patient confidentiality respected. Therefore, no risks to patients are anticipated. This strategy is consistent with single-site clinical audits which do not require consent and are typically LNR ethics applications.
Data storage and analysis: The abovementioned patient data will be extracted from the medical record of existing hospital systems or diagnostic laboratories... the data will be de-identified and stored within the secure [name] database or other suitable site-specific database where security standards are met (password-protected computer, limited to approved investigators)...
Disease area specific exception
Mitochondrial Disease - Participant group: This retrospective review will capture data from patients born during the study period, 1st January 1987 through to December 2020, or the end of the study.'"
"Email 1 - the request from MCRI
36 On 13 March 2020, a doctor who was a principal investigator of the Research Project at MCRI ('Dr PI') sent an email (copied to their colleague) titled 'mitochondrial epidemiology study' to two doctors at SCHN (Dr X and Dr Y). It read (my emphasis):
'Dear [Dr X and Dr Y]
... I thought I'd send a reminder of our list of paediatric onset mitochondrial patients born since 1987 in NSW. So far we have 176.
For now we would like you to help identify any patients we are missing if you can. (We are most likely to be missing ones who didn't have diagnostic biopsies/have molecular diagnoses not established through Melbourne).
Later we will prevail upon you to help us fill in gaps in the data (a lot of this will be related to survival).
Feel free to share with your teams and if there is anyone else (eg other centres or departments) you think we should ask directly for input, please let me know).'
...
Email 2 - suggested inclusion of a spreadsheet
38 Dr PI's colleague at MCRI 'replied all' saying:
'Hi [Dr PI]
I think it may be easier for [Dr X and Dr Y] if you send names as a cut down XL worksheet with existing columns for dob, dod (if known), age at presentation, gene, diagnosis to make it a bit easier to scan, re-order, etc.
Cheers'
39 'dob' was a reference to date of birth. 'dod' was a reference to date of death.
Email 3 - the MCRI Spreadsheet is provided
40 Dr PI then 'replied all' by email with an attached spreadsheet, which said:
'Thanks [MCRI colleague]
Here it is. It would be much appreciated it you could add where possible.'
41 The attached spreadsheet was titled 'NSW patients.xlxs'
42 One row related to the Applicant. MCRI had completed 9 of the columns with information it held relating to the Applicant, including his first and last name, postcode, date of birth, and sex. The remaining 3 empty columns were whether the patient was alive or deceased, the date of their last follow-up with the hospital, and the clinical manifestation.
Email 4 - SCHN's email reply with the attached Updated Spreadsheet
43 On 10 February 2021, Dr X from SCHN replied to the email from MCRI, attaching a spreadsheet titled 'NSW.patients.[Dr X's first name]. 10.02.2021.xlsx (Updated Spreadsheet).
44 Relevantly, the email from Dr X said:
'Please find attached the data for NSW patients. I have tried to fill in as much as details as possible.
- Data till 2020 December - I have entered the new data separately so that it is easy for [Dr PI] to insert to [their] master chart
- Highlighted in yellow - I have made corrections or entered new data
- Green - could not trace any records in track gene/power chart
- Red (six patients) Files in Randwick - I hope to access the files when I go to the clinic on 26/2/2021 & will be able to provide the data.
Please let me know if this is okay or if you need more details...'
(1) SCHN had completed the 3 previously blank columns to include the details relevant to the Applicant, including the fact he was still alive and his clinical manifestation; and
(2) the inserted information remained identifiable, because the Applicant's name remained on the relevant row."
"On 16 August 2023, the CEO of SCHN wrote to the Applicant's mother [30] saying, inter alia (my emphasis):
'We are sorry to hear that this matter has caused distress to you and your family. Thank you for your patience while a review was conducted into this matter. The Research Office at [SCHN] reviewed your concerns in accordance with the National Statement on Ethical Conduct in Human Research 2007 (updated 2018) and local and institutional policies.
It was found that [Dr PI] at MCRI (Melbourne) had received identifiable information regarding your son via an external diagnostic laboratory as part of an ethically approved national, multi-centre research project. This research project is titled "Australian Genomics Health Alliance: Preparing Australia for Genomic Medicine" and has ethics approval from the Melbourne Health Human Research Ethics Committee in Melbourne [Reference number: HREC/16/MH/251] for multiple Hospitals and laboratories across Australia as part of the National Health and Medical Research Council (NHMRC) National Mutual Acceptance Scheme. The ethics approval included a waiver of consent (considered under Australian Privacy Law) for the collection of retrospective data and review of patient records from relevant Hospitals. Under this Ethics Approval the Genetic Metabolic Disorders Service at the Children's Hospital at Westmead was asked to confirm the last date the patient was seen at the Service and a three-word description of their clinical manifestation at that time. Accordingly, our review concluded that the Genetic Metabolic Disorders Service at the Children's Hospital at Westmead did not breach your son's privacy....'"
(1) there was no breach of HPP 11, because the requirements of the research exemption in HPP 11(1)(f) had been satisfied;
(2) there had been a breach of HPP 5(1)(c) because the Applicant's health information had been provided to MCRI via an email attachment that had not been encrypted, which was contrary to SCHN's policies. It also noted that the emails did not specify that that (sic) the information was required for an HREC-approved research project, or contain any reference numbers or other information to confirm this was the case before the reply email was sent.
(3) the reviewer did not agree with the Applicant's characterisation that SCHN acted with ill intent or otherwise deliberately acted in a way to dismiss the complaint (First Request). Rather, the SCHN inadvertently failed to communicate clearly with the Applicant about the option for seeking a privacy internal review.
(1) Apologise to the Applicant for breaching HPP 5 and failing to be clear regarding their complaints handling process;
(2) Review and improve processes for SCHN staff regarding sharing and disclosure of health information in the context of research requests;
(3) Review and improve processes for handling privacy complaints; and
(4) Update the SCHN 'Privacy and your child's health information' webpage to accurately reflect how health information may be disclosed (particularly in respect of disclosure of health information for research purposes)."
'This publication outlines the requirements for the use and disclosure of health information for research and statistics. It has been prepared after public consultation. You should read it in conjunction with the HRIP Act and the Office of the Privacy Commissioner NSW "User Manual: Handbook to Health Privacy". If you are from the public health system, you should also read it in conjunction with the NSW Health Department's "Privacy Manual".
Part 1 explains some of the issues you need to consider when using and disclosing health information for research or statistics. It also includes a checklist and examples to help you decide what you should do in different circumstances.
Part 2 contains the statutory guidelines on research. You must comply with these statutory guidelines on research if you are seeking to use or disclose health information relying on the "research exemption" in HPP 10(1)(f) or 11(1)(f). These statutory guidelines on research are issued under section 64 of the HRIP Act.'"
"In respect of the HPPs, there should however be some room for flexibility where wording is unclear or difficult to apply, or where concepts such as 'reasonably necessary' and 'impractical' fall for consideration. It involves an assessment that must have regard to the required balance between the protection of privacy on the one hand and Parliament's intention to permit disclosure in prescribed circumstances: see the discussion by Bell J in Jurecek v Director, Transport Safety Victoria [2016] VSC 285 at [60]- [61] noting comments by the Australian Law Reform Commissioner in 2008 that 'Typically, some principles were expressed as prescriptions while others were expressed as high-level principles', and concluding that:
'61. The Information Privacy Principles are statutory provisions to which the established rules of interpretation apply, but they are statutory provisions of a particular kind. In the process of interpretation, I would take into account that the Principles are intended to operate in a practical and sensible way so as to afford privacy protection to personal information held by Victorian governmental organisations. In that process, the operation of principles expressed more generally should not be restricted and the operation of principles expressed more specifically should not be diluted.'"
"The opening words to HPP 11(1)
142 The opening words (chapeau) to HPP 11(1) provides:
(1) An organisation that holds health information must not disclose the information for a purpose (a secondary purpose) other than the purpose (the primary purpose) for which it was collected unless -
143 It is clear that SCHN satisfied the chapeau to HPP 11(1) because:
(1) SCHN was an organisation;
(2) SCHN held health information of the Applicant;
(3) '[T]he information' that was disclosed was the health information inserted by SCHN in the Updated Spreadsheet that was not already known to MCRI (refer discussion of 'disclose' above);
(4) It remained 'health information' because it was not de-identified (the Applicant's name etc. remaining on the relevant row); and.
(5) That health information was disclosed by SCHN for the purpose of the Research Project, which was a 'secondary purpose' (ie not the purpose for which it was originally collected).
144 My findings are also consistent with the SCHN letter (from the Chief Executive) to the Applicant's mother referenced above."
"151 First, I find that the Research Project was 'research' which was in the public interest. I agree with SCHN's submissions that the word 'research' is undefined and bears its ordinary meaning as the context does not suggest otherwise. The definition of 'research' covers all fields of research, and there is therefore a broad explanation at p 7 of the Research Guidelines:
'There are many definitions of research. It can be a systematic investigation to establish facts, principles or knowledge or a study to obtain or confirm knowledge. A defining feature of research is the validity of its results. The knowledge that is generated by research is valid in the sense that what is discovered about the particular facts investigated can be justifiably claimed to be true for all like facts.'
152 The reference to 'in the public interest' relevantly relates to the 'research', and not to the public interest in any other regard.
153 I find that the research described in the Study Proposal for the Research Project (to examine the feasibility and value of genomic testing in clinical practice and to provide research pathways for further investigation of undiagnosed cases) was research in the public interest. That finding is supported by the ethical approval of the Research Project by the MH HREC.
154 Secondly, I find that the disclosure by SCHN of the Applicant's health information was 'reasonably necessary' for that research in the public interest.
(1) I find that the Applicant (unknown to him) formed part of the 'baseline cohort' for the mitochondrial disease flagship of the Research Project: he was born after 1 January 1987, had mitochondrial disease, and was within this retrospective cohort. This was confirmed by Dr PI at MCRI (above at par 54) and further supported by the email request from MCRI referring to the same relevant dates of the cohort as described at section 4.5 of the Study Protocol.
(2) In that context, I find that it was 'reasonably necessary' for the purpose of the Research Project for the Applicant's health information to be disclosed. I also observe that 'reasonably necessary' is to be construed as at the relevant time of the actual disclosure. It does not require a 'tracing' of that information to confirm how and whether it was ultimately used for the Research Project. Nor is it the Tribunal's task in this case to forensically determine whether the health information was unreliable and of questionable use to the Research Project, as was adverted to in the Applicant's submissions.
"157 Accordingly, SCHN must satisfy HPP 11(1)(f)(i)(A). This requires a finding (in respect of the identified 'secondary purpose' of research) that:
(A) that purpose cannot be served by the disclosure of information that does not identify the individual or from which the individual's identity cannot reasonably be ascertained and it is impracticable for the organisation to seek the consent of the individual for the disclosure
158 Again, there are two requirements in HPP 11(1)(f)(i)(A).
159 First, I find that the research purpose could not be served by disclosing de-identified (or unidentifiable) information.
160 MCRI had obtained information from the Victorian laboratory (not SCHN) which was populated on the MCRI Spreadsheet which was then sent to SCHN. Dr PI of MCRI stated that this information was sought to be 'verified' through the request made to SCHN for the additional information.
161 I find that MCRI needed to compile the de-identified information from the two sources to ensure that the information accorded to the same patient. In these circumstances, I find that the de-identified information was therefore required to be collected from SCHN, and disclosed by it to MCRI.
162 Contrary to the submissions of the Applicant, I am satisfied that the reference in the Study Protocol to 'will be de-identified', is to a subsequent de-identification undertaken by the 'collector' (MCRI), which - on the facts before me - collected information from two different sources (the laboratory and SCHN). It follows that I am satisfied that the Research Project approved by the MH HREC authorised this to occur by way of the collection of 'health information' that would subsequently be de-identified by MCRI, and that MCRI required identified information to verify it from two sources, consistent with the Explanatory Notes at p8) which also contemplate this situation:
'Sometimes de-identified information cannot achieve the purpose of the research or statistical activity. This could be, for example, where a project involves linking information about individuals from two or more sources and you need identified information to correctly link records from each data source.'
163 I read the reference above to 'linking information' or 'linking records' as a generic statement in the context of HPP 11(1)(f), versus a reference to 'data linkage' which is the subject of HPP15.
164 Secondly, I find that it was 'impracticable' for SCHN to seek the consent of the individual.
165 'Impracticable' is not defined. As SCHN submits, it has been found by the Tribunal to accord with 'impossible in practice', in the context of HPP3, in respect of 'collection': ALZ v Workcover NSW [2014] NSWCATAD 49, [70], [76]. Footnote 7 to section 4.2 of the Research Guidelines identifies the following factors relevant in assessing whether it is impracticable to seek consent for the purpose of the research exemption (my emphasis):
• The size of the population involved in the research;
• The proportion of individuals who are likely to have moved or died since the health information was originally collected;
• The risk of introducing potential bias into the research, thereby affecting the generalisability and validity of the results;
• The risk of creating additional threats to privacy by having to link information in order to locate and contact individuals to seek their consent;
• The risk of inflicting psychological, social or other harm by contacting individuals with particular conditions in certain circumstances;
• The difficulty of contacting individuals directly when there is no existing or continual relationship between the organisation and the individuals;
• The difficulty of contacting individuals indirectly through public means, such as advertisement and notices;
• Whether the additional resources needed to obtain consent will impose an undue hardship on the organisation.
(1) It is accepted by the parties that the Updated Spreadsheet contained approximately 300 patient rows. The information did not relate solely to the Applicant;
(2) Not all the individuals listed in the Updated Spreadsheet would have an existing or continual relationship with SCHN (indeed, the Applicant himself did not); and
(3) The information sought included whether the patient (born after 1 January 1987) was alive or dead ("dod"). Given the nature of the disease affecting this retrospective cohort, and acknowledging the Applicant's own circumstances regarding his sibling, it is reasonable to conclude that some of the individuals listed in the Updated Spreadsheet were deceased and seeking to contact them could risk inflicting unnecessary psychological harm on their families.
167 For these reasons, I find that it was impracticable to seek the consent of the Applicant.
(1) are 'legally binding documents that define the scope of particular exemptions in the health privacy principles'; and
(2) 'describe how the exemption applies and what an agency needs to do in order to comply with the exemption. They are as important as the exemption itself.'"
1. Application of the statutory guidelines
1.1 These statutory guidelines define the scope and applicability of the 'research exemption' in Health Privacy Principle 10(1)(f) and 11(1)(f). These statutory guidelines require research proposals to be submitted to a Human Research Ethics Committee for approval, and provide a mechanism for Human Research Ethics Committees to weigh the public interest in the research or the compilation or analysis of statistics against the public interest in the protection of privacy. In order for the proposal to be approved, the public interest in the research or the compilation or analysis of statistics activity must substantially outweigh the public interest in maintaining the level of privacy otherwise afforded by the Health Privacy Principles.
Failure to comply with statutory guidelines constitutes a breach of the Act
1.2 An organisation proposing to use or disclose health information relying on the 'research exemption' in Health Privacy Principles 10(1)(f) or 11(1)(f), must comply with these statutory guidelines in order for the health information to be lawfully used or disclosed. Failure to comply with these statutory guidelines constitutes a breach of the Health Privacy Principles and the Health Records and Information Privacy Act 2002 (NSW)."
"198 I find that HPP 10 does not apply, because (on the evidence before the Tribunal) SCHN did not 'use' the Applicant's health information for its own purposes, such as using it internally for their own operations or analysis. Rather, SCHN only handled the information to prepare the spreadsheet for the purpose of disclosure to MCRI.
199 This view was confirmed on appeal by the Appeal Panel of this Tribunal in AIN v Medical Council of New South Wales [2017] NSWCATAP 23 ("AIN"). The Appeal Panel noted that the PPIP Act established separate rules for use and disclosure. It held that the steps taken were 'concerned with the making of the disclosure', and 'there was no act of internal use of personal information', and thus IPP 9 did not apply (at [81]-[82]).
200 The Tribunal isn't bound by the doctrine of precedent to follow earlier decisions, but it should ordinarily follow decisions of the Appeal Panel and decisions of the Tribunal as constituted by the President or a Deputy President, unless they are clearly wrong. There is nothing 'clearly wrong' arising from my review of the decision in AIN, and I therefore see no reason to depart from its approach.
201 As a result, I find that HPP 10 does not apply as the actions taken by SCHN to prepare information for disclosure was not a separate 'use'.
202 Further, if I am in wrong, HPP 10 mirrors the wording of HPP 11, other than referring to the 'use' rather than the 'disclosure' of the information. Further, the same Research Guidelines apply to both HPP 10(1)(f) and HPP 11(1)(f). As any 'use' was directly related to the disclosure, it follows that the requirements of HPP 10, including the research exemption in HPP 10(1)(f) were satisfied on the same basis considered above in respect of HPP 11(1)(f)."
"Ground 1: The Tribunal erred in its interpretation and application of the 'research exemption' in HPP 10(1)(f) and HPP 11(1)(f) in the Health Records and Information Privacy Act 2002 (NSW) (HRIP Act).
(a) The Tribunal adopted an improper construction of the chapeau requirement of 'disclosure...reasonably necessary for research ... in the public interest.'
(b) The Tribunal applied the incorrect test for 'impracticable' in HPP 11(1)(f) and HPP 10(1)(f).
(c) The Tribunal asked the wrong questions when determining adherence to the Statutory Guidelines on Research for the purpose of HPP 11(l)(f)(iii) and HPP 10(1)(f)(iii).
Ground 2: The Tribunal erred in its construction of HPP 10 in the HRIP Act in respect of the meaning of 'use' of health information.
Ground 3: The Tribunal failed to afford procedural fairness, in that it failed to allow the Appellant a reasonable opportunity to present his case at hearing and failed to ensure the Appellant had a proper opportunity to understand the case against him."
"Do you support the original orders made by the Tribunal which the Appellant/s challenges for reasons other than those given by the Tribunal?"
"Where a respondent wants to argue that the orders appealed against were correct but for reasons different from those given by the Tribunal, the respondent should complete the section in the Reply to Appeal which requires the respondent to state whether there are any other reasons why the Tribunal's orders were correctly made."
See also the discussion in M H Investments Aust Pty Ltd v Hurstville City Council [2015] NSWCATAP 180 at [32]- [36].
"The Tribunal erred in finding, to the extent that it did, that the phrase 'in accordance with' in HPP 11(1)(f)(iii) requires strict compliance with the document issued by the Privacy Commissioner titled 'Statutory Guidelines on Research' (Research Guideline). In particular, the Tribunal erred in having regard to statements in the Research Guideline itself to determine the nature of compliance required by HPP 11(1)(f)(iii).
The Tribunal ought to have found that the phrase 'in accordance with' in HPP 11(1)(f)(iii) requires substantial compliance with the Research Guideline, in the sense of broad compatibility."
Ground 1(a) - the construction of each chapeau to HPP 10(1)(f) and HPP 11(1)(f)
"Ground 1: The Tribunal erred in its interpretation and application of the 'research exemption' in HPP 10(1)(f) and HPP 1 1(l)(f) in the Health Records and Information Privacy Act 2002 (NSW) (HRIP Act).
(a) The Tribunal adopted an improper construction of the chapeau requirement of disclosure...reasonably necessary for research ... in the public interest.'"
10 Limits on use of health information
(1) An organisation that holds health information must not use the information for a purpose (a secondary purpose) other than the purpose (the primary purpose) for which it was collected unless -
...
(f) Research
the use of the information for the secondary purpose is reasonably necessary for research, or the compilation or analysis of statistics, in the public interest and -
...
11 Limits on disclosure of health information
(1) An organisation that holds health information must not disclose the information for a purpose (a secondary purpose) other than the purpose (the primary purpose) for which it was collected unless -
...
(f) Research
the disclosure of the information for the secondary purpose is reasonably necessary for research, or the compilation or analysis of statistics, in the public interest and -
...
(1) the research project, "was 'research' which was in 'the public interest'" (Decision at [151),
(2) the reference in the chapeau to "in the public interest" relevantly relates to the "research", and not to "the public interest in any other regard" (Decision at [152]),
(3) restated its finding that the research was in the public interest, and commented that the finding was supported by "the ethical approval of the Research Project by the MH HREC" (Decision at [153]).
"Linguistically, the natural reading of the chapeau is that the phrase 'in the public interest' qualifies the 'research' (or statistical analysis), being the noun it immediately follows. Had the legislature intended that it qualify 'the disclosure', the chapeau would have more naturally have been drafted: 'the disclosure of the information for the secondary purpose is reasonably necessary for research, and is in the public interest'."
"To be 'in the public interest' the outcome of a research or statistical activity should have a positive impact on, or be relevant to, the community or a segment of the community as distinct from being a matter of purely private or personal interest. Some examples that could be considered to be 'in the public interest' include research and statistics on communicable diseases, cancer, heart disease, mental health, injury control, diabetes and the prevention of childhood diseases."
The construction of each chapeau to HPPs 10 and 11
"It may readily be accepted that most questions about what is in 'the public interest' will require consideration of a number of competing arguments about, or features or 'facets' of, the public interest. As was pointed out in O'Sullivan v Farrer:
'[T]he expression "in the public interest", when used in a statute, classically imports a discretionary value judgment to be made by reference to undefined factual matters, confined only "in so far as the subject matter and the scope and purpose of the statutory enactments may enable ... given reasons to be [pronounced] definitely extraneous to any objects the legislature could have had in view".'
That is why a question about 'the public interest' will seldom be properly seen as having only one dimension..."
"The expression 'in the public interest', when used as the criterion for the exercise of a statutory discretion, usually imports a discretionary value judgment confined only by the subject matter and the scope and purpose of the legislation. The ascertainment of the subject matter and the scope and purpose of the legislation will enable a court to determine whether reasons which are given are definitely extraneous to any object a legislature could have had in view. See O'Sullivan v Farrer [1989] HCA 61; (1989) 168 CLR 210 at 216, and Water Conservation Commission v Browning [1947] HCA 21; (1947) 74 CLR 492 at 505: McKinnon's case per Hayne J at [55]: Visnic v Australian Securities and Investments Commission [2007] HCA 24; (2007) 81 ALJR 1175 at [36] per Kirby J. Although Jacobs J said in Sinclair v Mining Warden at Maryborough [1975] HCA 17; (1975) 132 CLR 473 at 487, that the public interest is an 'indivisible concept', there may be competing aspects to the public interest. See Re Queensland Electricity Commission; Ex parte Electrical Trades Union [1987] HCA 27; (1987) 61 ALJR 393 at 400 and the examples given by Jacobs J in Sinclair v Mining Warden (supra). Jacobs J in Sinclair was considering the meaning of the words 'public interest' in a regulation which required a Warden to recommend rejection of an application if, in his opinion, 'the public interest or right will be prejudicially affected' by its grant. Jacobs J, at 487, referred to the width of the expression 'public interest', and noted that the public interest in that case could tell against the grant of the mining lease even though particular interests of an individual were the only interests primarily affected."
"...When used in a statute, the term derives its content from 'the subject matter and the scope and purpose' of the enactment in which it appears. The court is not free to apply idiosyncratic notions of public interest."
"...The unit of communication by means of language is the sentence and not the parts of which it is composed. The significance of individual words is affected by other words and the syntax of the whole...."
See also Ghali v Commissioner of State Revenue [2013] NSWCA 340; (2013) 85 NSWLR 378 at 383 (Basten JA).
(1) be reasonably necessary for the research or the compilation or analysis of statistics;
(2) be in the public interest, and;
(3) satisfy the three separate requirements in (1)(f)(i), (ii) and (iii).
(1) the disclosure (or use) is reasonably necessary for the research; and
(2) the research is in the public interest.
Determination that "in the public interest" relates to "use" or "disclosure"
Whether a decision about the public interest is a discretionary decision
Ground 1(c) - meaning of "in accordance with" the statutory guidelines
"Ground 1: The Tribunal erred in its interpretation and application of the 'research exemption' in HPP 10(1)(f) and HPP 1 1(l)(f) in the Health Records and Information Privacy Act 2002 (NSW) (HRIP Act).
...
(c) The Tribunal asked the wrong questions when determining adherence to the Statutory Guidelines on Research for the purpose of HPP 11(l)(f)(iii) and HPP 10(1)(f)(iii)."
...is in accordance with guidelines, if any, issued by the Privacy Commissioner for the purposes of this paragraph,...
(1) "'the Tribunal failed to consider the specific requirements for written proposals for the proposed use or disclosure of health information in accordance with the research exemption'";
(2) "'the Tribunal failed to consider whether the MH HREC had complied with the Statutory Guidelines'";
(3) "'the Tribunal failed to consider how the Statutory Guidelines applied to information-sharing between organisations'"; and
(4) "'the Tribunal failed to consider the application of section 2.11 of the Statutory Guidelines'."
SCHN's contention that the Decision is supported on other grounds
(1) "PART 1: USING AND DISCLOSING HEALTH INFORMATION FOR RESEARCH" at pages 4 to 11; and
(2) "PART 2: STATUTORY GUIDELINES ON RESEARCH" at pages 13 to 22.
(1) Appendix A contains HPPs 10 and 11 of Sch 1 to the HRIP Act.
(2) Appendix B contains an extract from the Joint NHMRC/AVCC Statement and Guidelines on Research Practice, Section 2, on Data Storage and Retention. We note that the abbreviations in the previous sentence are of the National Health and Medical Research Council and the Australian Vice Chancellors' Committee.
(3) Appendix C contains a template report form to be provided to the Privacy Commissioner by HRECs.
"The Explanatory Notes clearly state that the Research Guidelines:
(1) are 'legally binding documents that define the scope of particular exemptions in the health privacy principles'; and
(2) 'describe how the exemption applies and what an agency needs to do in order to comply with the exemption. They are as important as the exemption itself.'"
"... does not create a norm of conduct binding on an individual or specify that conduct in contravention of such a norm is 'unlawful'. It creates norms confined in their application to public sector agencies. The only consequence of contravention of an information protection principle or a privacy code of practice is that Pt 5 of the PPIP Act applies to such conduct. ..."
(1) The guidelines were originally issued in 2004. They have been re-issued since, but have always stated, in their explanatory materials, that they are legally binding (original emphasis). If SCHN's concerns are correct, why have the concerns not been addressed by the legislature?
(2) The use of the term "guideline", as opposed to "rules", "regulations" or "requirements", is consistent with the use of the term under federal privacy law, namely the preexisting NHMRC Guidelines under ss 95 and 95A of the Privacy Act 1988 (Cth). The NSW guidelines, so it is said, are "intended to be broadly consistent with" the guidelines that "exist at the federal level".
(3) The guidelines were correctly found to be legally binding by the Tribunal.
(1) two other Acts (see s 5(3)(d), (h));
(2) matters prescribed by the regulations (s 16(3)(b));
(3) management plans (s 19(3)(f)); and
(4) guidelines issued by the Privacy Commissioner (which are too numerous to conveniently list here, but relevantly for our purposes include HPP 10(1)(f)(iii) and HPP 11(1)(f)(iii)).
62 Exempting organisations from complying with Principles and codes
(1) The Privacy Commissioner may, in accordance with this section, make a written direction that -
(a) an organisation is not required to comply with a Health Privacy Principle, a provision of Part 4 or a health privacy code of practice, or
(b) the application of a Health Privacy Principle, a provision of Part 4 or a code to an organisation is to be modified as specified in the direction.
Did the Tribunal strictly apply the requirements of the guidelines when concluding that the guidelines had been complied with?
Use or disclosure
2.1 Where an organisation proposes to use or disclose health information under the 'research exemption' in Health Privacy Principle 10(1)(f) or 11(1)(f), a research proposal must be submitted to an HREC for approval. The research proposal must follow the procedures set out in this section and will be considered by an HREC only if the proposal also satisfies the requirements in section 1 of these statutory guidelines.
Written proposal to be submitted to HREC.
2.5 An organisation proposing to disclose health information for the purpose of research or the compilation or analysis of statistics, in the public interest, pursuant to Health Privacy Principle 10(1)(f), must submit a written proposal for that activity to an HREC. The information to be included in such a written proposal is set out in section 2.9 of these statutory guidelines.
Where written notification of HREC decision is provided by collector
2.6 An organisation may disclose health information to a collector for the purpose of research or the compilation or analysis of statistics, in the public interest without submitting a written proposal to an HREC if it receives written notification of the HREC approval for health information to be collected from it by the collector as set out in section 3.4 of these statutory guidelines. The written notification must include a copy of the collector's proposal to the HREC and the HREC's response. However, the disclosing organisation may still choose to submit the proposal to an HREC.
Option of submitting a joint proposal
2.7 An organisation seeking or approached to disclose health information may submit a joint written proposal in conjunction with the collector to an HREC for approval to disclose (and approval for the collector to collect) the health information. The joint written proposal may be submitted to an HREC selected by the collector or by the disclosing organisation, as negotiated by the collector and the disclosing organisation.
"Otherwise, in the absence of any such proposal, had the respondent received 'written notification of the HREC approval for health information to be collected from it by the collector as set out in section 3.4 of these statutory guidelines'?"
Compliance with sections 1.4 and 1.5 of the guidelines
Conditions for organisations seeking to use or disclose
1.4 Where an organisation seeks to rely on these statutory guidelines to lawfully use or disclose health information it must:
(a) be satisfied that the research or the compilation or analysis of statistics activity in which the health information is to be used or disclosed has been approved by a Human Research Ethics Committee (HREC) under these statutory guidelines; and
(b) be satisfied that the HREC granting the approval satisfies the conditions in section 1.5 of these statutory guidelines; and
(c) comply with other duties imposed upon it by these statutory guidelines.
(a) only give approval under the Act for the collection, use or disclosure of health information for the purpose of research or the compilation or analysis of statistics, in the public interest, in accordance with these statutory guidelines;
(b) be constituted and functioning in accordance with the National Statement on Ethical Conduct in Research Involving Humans (2: Human Research Ethics Committees); and
(c) comply with sections 4.1-4.10 of these statutory guidelines.
"A ground of no evidence is a contention that the Tribunal exceeded its authority by determining a matter irrationally or capriciously because there is no evidence to justify the conclusion: Australian Broadcasting Tribunal v Bond [1990] HCA 33; (1990) 170 CLR 321 at pp 367-368; [1990] HCA 33; Australian Gas Light Co v Valuer-General (1940) 40 SR (NSW) 126 at 138. It goes to the nature of the Tribunal's task."
"50 ...where a body such as a local council is required by a statute to address a question posed by that statute or by an instrument referred to by the statute, it must address that very question. If it does not do so, it will be in breach of the statute, even though it may have adverted to the topic of the question.
51 However, when a court comes to consider whether or not such a breach has occurred, the court will have regard to the presumption of regularity. This presumption was relevantly stated as follows by McHugh JA in Minister for Natural Resources v. NSW Aboriginal Land Council (1987) 9 NSWLR 154 at 164 at follows:
Where a public official or authority purports to exercise a power or to do an act in the course of his or its duties, a presumption arises that all conditions necessary to the exercise of that power or the doing of that act have been fulfilled.
See also Morris v. Kanssen [1946] AC 459 at 475; Western Stores Ltd. v. Orange City Council [1971] 2 NSWLR 36 at 46-7.
52 ... The presumption is a presumption of fact, associated with a reasonable inference based on what ordinarily happens in the ordinary course of human affairs: see McLean Brothers & Rigg Ltd. v. Grice [1906] HCA 1; (1906) 4 CLR 835 at 849-51 per Griffiths CJ. In deciding whether the presumption of regularity is rebutted, this inference from the ordinary course of human affairs carries some weight, which may vary according to the proved circumstances."
"... where acts are of an official nature, or require the concurrence of official persons, a presumption arises in favour of their due execution. In these cases the ordinary rule is omnia praesumuntur rite et solenniter esse acta donec probetur in contrarium - everything is presumed to be rightly and duly performed until the contrary is shown."
Matters warranting review of ethical approval
2.11 Those who seek to use or disclose health information for the purposes of research or the compilation or analysis of statistics, in the public interest must immediately report to the HREC anything that might warrant review of ethical approval of the research or the compilation or analysis of statistics proposal. [See: paragraph 2.37, 'Human Research Ethics Committees', National Statement (1999)].
Ground 2: The Tribunal erred in its construction of HPP 10 in the HRIP Act in respect of the meaning of 'use' of health information.
"Was there a breach of HPP 10 (Limits on use)?
198 I find that HPP 10 does not apply, because (on the evidence before the Tribunal) SCHN did not 'use' the Applicant's health information for its own purposes, such as using it internally for their own operations or analysis. Rather, SCHN only handled the information to prepare the spreadsheet for the purpose of disclosure to MCRI."
(1) Following the decision of the Appeal Panel in AIN v Medical Council of New South Wales [2017] NSWCATAP 23 (AIN). The Tribunal erred in following AIN, as AIN was concerned with the meaning of "use" for the purposes of the data quality standard in s 16 of the PPIP Act, not the prohibition against secondary use of health information in HPP 10.
(2) Adopting "an inappropriate view of the relevant 'conduct'".
"... to the Tribunal's factual finding at [198] that SCHN did not 'use' FZP's health information for its own purposes, such as using it internally for their own operations or analysis, but rather, SCHN only handled the information to prepare the spreadsheet for the purpose of disclosure to MCRI."
FZP's submission that the Tribunal erred in following AIN
16 Agency must check accuracy of personal information before use
A public sector agency that holds personal information must not use the information without taking such steps as are reasonable in the circumstances to ensure that, having regard to the purpose for which the information is proposed to be used, the information is relevant, accurate, up to date, complete and not misleading.
"20 'Use' is understood to refer to action taken by the agency to use information for its own purposes. A benefits-payment agency might 'use' a payee's personal information to undertake termination action on the ground that eligibility conditions are no longer being fulfilled.
21 'Disclosure' is understood to refer to the action taken by an agency to provide the information to a third party external to the agency, such as another agency or a private sector functionary, e.g. the benefits-payment agency 'discloses' information about a payee in response to a police warrant. Disclosure will result in the information passing into the hands of an external party over whom the source agency has no control as to what might then happen to the information. Qualitatively an unlawful 'disclosure' may pose a more serious threat to an individual's privacy than an unlawful internal 'use'. Similarly a failure to check data for accuracy, completeness and relevance before disclosure may have more serious consequences than a failure of this kind before data is used.
22 This difficulty has given rise to consideration in Appeal Panel cases of the question of whether the data quality standard (s 16) is confined to uses in the narrow sense or bears a broader interpretation that treats the act of disclosure as necessarily involving a prior 'use' of the data, the use being the process of deciding whether to respond to the request for disclosure. There is an apparent conflict in the authorities.
23 After reviewing the authorities, the Tribunal decided that in a setting such as the present the disclosure was one that served an internal administrative purpose of the agency (i.e. dealing appropriately with a workers compensation claim) and therefore it could properly be concluded that the 'use' standard was attracted. On this basis therefore, the principal before speaking as he did to the psychologist should have taken such steps as were reasonable in the circumstances to ensure that, having regard for which the information is proposed to be used, the personal information he disclosed about VK was relevant, accurate, up to date, complete and not misleading. He took no steps.
24 The original case in the relevant sequence of authority is Director General, Department of Education and Training v MT [2005] NSWADTAP 77. The Appeal Panel expressed the view that s 16 applies to all disclosures of personal information because this is a form of use of information. The Department's submissions note that this decision was reversed on appeal on another point, Director General, Department of Education and Training v MT [2006] NSWCA 270, and the Court did not directly refer to that aspect of the Appeal Panel's reasons. The Department submits that the reasoning of the Court at [43]-[45] tends to treat s 16, s 17 and s 18 as referring to separate acts. The Department considers that this is the explanation for the more qualified approach seen in the next case in the sequence, PN, where the Appeal Panel says at [35]-[36]:
35 We mention these matters by way of background, and in support of the view adopted by the Tribunal in this case, i.e. that the data quality standard reflected in s 16 does not apply to an external disclosure of personal information. The only way it can be brought into account is if it can be shown that the external disclosure was preceded by some form of internal use of the information.
36 In this case, perhaps it could be argued that the principal's obligation of disclosure arose from a contractual or legislative duty binding on an employer under insurance law. It might then be argued that her conduct served an internal administrative purpose of the Department, being compliance with that obligation, and thereby her conduct involved a 'use' of the information preceding 'disclosure'. It might be said that it was not a 'mere' disclosure, to which no forethought could practically be given, as might occur when a subpoena is actioned; or an urgent request is made by a law enforcement agency in circumstances where disclosure would be permitted by law.
25 The Tribunal was attracted to the suggestion raised in para [36] above. It applied the approach there and commended it as a preferable policy, see its reasons at [35].
26 On reflection, the Appeal Panel considers that the 'use' requirement and the 'disclosure' requirement do not overlap in the way that was suggested in the MT decision and the observations in PN should be read in that light. Further the Appeal Panel in PN noted more recent developments in privacy law, especially at Commonwealth level, where now the data quality standard is applied expressly to both 'uses' and 'disclosures' of personal information.
27 Each case will depend on its facts. There will, we expect, be circumstances where there is an identifiable internal 'use' transaction and an identifiable external 'disclosure' transaction in the one sequence of events. So to go back to the earlier example. The agency might take internal action to terminate a benefit and refer the information to the police for action in relation to say some suspected fraud that has given rise to a wrong payment of benefits. The internal action would attract the 'use' data quality principle.
28 But there will be other circumstances where the situation does not involve any parallel internal action.
29 We will extend to the merits and dispose of this point. In our view this is a case of the latter type. On all the evidence, the principal's action was done in response to the psychologist's request for relevant input to assist her in making the assessment. There was one act, and it was an act of disclosure."
"It is important to bear in mind that giving information to an outside person or agency, as occurred here, is not a use of personal information but is to be considered under the disclosure principle in s 18: JD v Department of Health [2005] NSWADT 44 at [93]; Department of Education & Communities v VK [2011] NSWADT 61 at [20-29]. While it can be argued that the Agency's conduct in preparing and sending the ADB letter constitutes a use and then a disclosure of AFC's personal information by the Agency, I think this an artificial construct. The reality is, and I am satisfied that, writing and despatching the ADB letter should be viewed as one course of conduct that falls to be considered as a disclosure."
"In our opinion, on the facts, there was no act of internal use of personal information of the kind envisaged by s 16. To conclude otherwise is artificial. In this respect, we agree with the approach taken in AFC v The Sydney Children's Hospital Speciality Network (Randwick and Westmead) [2012] NSWADT 189 at [42]. This involved the preparation of a letter, including gathering information to include in the letter. In our opinion, it is analogous to the present situation. In both, the steps involved are concerned with the making of the disclosure. There is no evidence of any separate use of the product of these steps other than the making of the disclosure."
"... the provision of access to an individual's personal information under s 14 of the Privacy Act, alone, does not constitute use for the purpose of s 16 of the Privacy Act. Section 16 is not a prerequisite to s 14 of the Privacy Act."
Whether the Tribunal was wrong to follow AIN does not raise a question of law
"I think it is a fundamental rule of construction that any document should be construed as far as possible so as to give the same meaning to the same words wherever those words occur in that document, and that that applies especially to an Act of Parliament, and with especial force to words contained in the same section of an Act."
"An erroneous conclusion that facts properly determined fail to satisfy a statutory test, for example, ... failure to provide suitable employment will ordinarily be an erroneous conclusion of fact. It is only in marginal cases that the statutory test is satisfied or not satisfied as a matter of law, because no other application is reasonably open: Hope v Bathurst City Council; Australian Gas Light Co v Valuer-General."
(1) The text of the email from Dr X to MCRI dated 10 February 2021 in which Dr X outlined the work done over the period of 11 months since the initial email had been received from MCRI, in March 2020. This included correcting data provided by MCRI, tracing records using "track gene/power chart", accessing and providing information from records within SCHN and entering new data. One can infer from both the time taken, and the number of records involved, that this was a considerable task.
(2) The evidence that SCHN was a member of the Australian Genomic Health Alliance, who had organised the research, was a participating institution in the research, and was receiving funding for its participation in the research.
(3) The basis of the complaint made to SCHN by FZP, as summarised in the internal review, was "[t]he use, access and disclosure of his health information without consent forms": paragraph 1.1 of the internal review.
"Ground 3: The Tribunal failed to afford procedural fairness, in that it failed to allow the Appellant a reasonable opportunity to present his case at hearing and failed to ensure the Appellant had a proper opportunity to understand the case against him."
(1) Prejudged an issue, specifically FZP's contention that SCHN did not act in accordance with the guidelines because there was no evidence of prospective HREC approval for the specific activity of use and disclosure of FZP's health information, by stopping FZP's submission on the issue and saying "I don't even care" (Tcpt, 21 March 2025, p 71(24)). We refer to this as the authorisation issue.
(2) Frequently intervened in the agent's arguments, preventing them from being made.
(3) Failed to properly control the proceedings, with particular reference to the Senior Member allowing the agent's husband and FZP's father (who was there to assist her) to speak during the latter half of the morning. The Senior Member withdrew the FZP's father's permission to speak after lunch. FZP claimed this allowed the proceedings to descend into "chaos" for some time.
(4) Created an environment in which the agent was so intimidated with respect to what was relevant and the Tribunal's requirements, that she made forensic choices that were not in FZP's interest, and did not pursue arguments available to her. The interventions of the Tribunal, it is said, "shaped" her presentation of her case. This included FZP's agent conceding that securing FZP's information was authorised by the research project and the MH-HREC (the authorisation issue), and not fully putting arguments concerning whether the research was undertaken in accordance with the guidelines.
(1) By seeking to raise the authorisation issue, the agent was raising an issue that had not been the subject of submissions by any party, including FZP. Indeed, an examination of the papers shows, the administrative review application had proceeded on the basis that FZP's health information was within the scope of the research project. The Tribunal stated that the authorisation issue was not one raised by the parties, and was not before it.
(2) Efforts by FZP's agent to pursue the irrelevant matters were stopped by the Tribunal, which sought to have the agent address matters of relevance that were in issue.
(3) Only FZP's mother had been given leave to act as FZP's agent. During the hearing, both his mother and father talked and engaged with the Tribunal, sometimes at the same time.
(4) There is little probative evidence that the Senior Member's conduct of the proceedings resulted in the agent being intimidated, and making forensic decisions as a result. There was no evidence from the agent before the Appeal Panel in the form of a statement from her. The agent withdrew the authorisation issue after lunch on the day of the hearing saying (Tcpt, 21 March 2025, p 131(26)):
"... it was an HREC approved study. No argument there. Section 4.5, which is what we've been referring to by the HREC, was approved as you saw it, and so we've got no arguments about all the documentation with it...."
(5) With respect to other arguments that FZP contends the agent was unable to put relating to the guidelines, SCHN made reference to the relatively detailed submissions relating to those issues made by the agent later in the afternoon of the hearing (Tcpt, 21 March 2025, p 144(41) onwards). SCHN submits that FZP's agent was not prevented from, and did make, those arguments.
"309 Courts have an overriding duty to ensure that a trial is fair: Dietrich v R [1992] HCA 57; 177 CLR 292. This entails ensuring that the trial is conducted fairly and in accordance with law: MacPherson v The Queen [1981] HCA 46; 147 CLR 512 per Gibbs CJ and Wilson J at [16] 525. The duty reposes in the individual judicial officer hearing a case. In the context of an unrepresented litigant, the duty requires that a person does not suffer a disadvantage from exercising the recognised right of a litigant to be self-represented: R v Zorad (1990) 19 NSWLR 91 at 94-95. In MacPherson Mason J, at [31] 534, noted that:
'A trial in which a judge allows an accused to remain in ignorance of a fundamental procedure which, if invoked, may prove to be advantageous to him, can hardly be labelled as "fair".'
310 However, the court's duty is not solely to the unrepresented litigant. The obligation is to ensure a fair trial for all parties. For this reason, the duty is usually stated in terms that require that the impartial function of the judge is preserved, whilst also requiring the judge to intervene where necessary to ensure the trial is fair and just: Tomasevic v Travaglini [2007] VSC 337; 17 VR 100 at [95]; Barghouthi v Transfield Pty Ltd [2002] FCA 666; 122 FCR 19, 23; NAGA v Minister for Immigration and Multicultural and Indigenous Affairs [2002] FCA 944, [11]; Nagy v Ryan [2003] SASC 37, [52]-[53].
311 Insofar as the duty relates specifically to an unrepresented party, it has been said that a trial judge has an obligation to take appropriate steps to ensure that the unrepresented litigant has sufficient information about the practice and procedure of the court, so far as is reasonably practicable for the purpose of ensuring a fair trial. The application of that principle will vary depending upon the circumstances of the case: Jae Kyung Lee v Bob Chae-Sang Cha per Basten JA at [48]. See also Abram v Bank of New Zealand (1996) ATPR 41-507, 43,341, 43,347; Microsoft Corporation v Ezy Loans Pty Ltd [2004] FCA 1135; (2004) 63 IPR 54; Pezos v Police [2005] SASC 500; (2005) 94 SASR 154.
312 Although the duty of a trial judge to assist an unrepresented litigant is cast in active terms, it does not extend to advising the accused as to how his or her rights should be exercised: R v Gidley (1984) 3 NSWLR 168. Rather, the judge has to put the unrepresented litigant in the position of being able to make an effective choice, a duty which applies notwithstanding the adversarial character of a criminal trial: McPherson per Mason J at 534. The duty is the same in a civil proceeding, with such modifications as are called for to take account of civil procedures. However, it is not the function of the court to give judicial advice to, or conduct the case on behalf of, the unrepresented litigant: Bhagwanani v Martin (1999) 204 LSJS 449; [1999] SASC 406 ; Clark v State of New South Wales (No 2) [ 2006] NSWSC 914.
313 The touchstone at all times remains that of fairness. In Rajski v Scitec Corporation Pty Ltd (Court of Appeal, 16 June 1986, unreported) Samuels JA, at 14, stated:
'But the court should be astute to see that it does not extend its auxiliary role so as to confer upon a litigant in person a positive advantage over the represented opponent ... At all events, the absence of legal representation on one side ought not to induce a court to deprive the other side of one jot of its lawful entitlement ... An unrepresented party is as much subject to the rules as any other litigant.'
...
315 There may be a fine tension in striking the balance between providing assistance to an unrepresented litigant and ensuring a fair trial for all parties. However, it is the task of the judge to strike that balance. In Minogue v Human Rights and Equal Opportunity Commission [1999] FCA 85; (1999) 84 FCR 438 at 446 the Full Federal Court dealt with the tension between the duty of the trial judge to ensure a fair trial and the requirement of impartiality:
'A trial judge often faces something of a dilemma. While he or she may be bound to provide some advice and assistance to an unrepresented litigant, the authorities make it clear that the Judge should not intervene to such an extent that he or she cannot maintain a position of neutrality in the litigation: Burwood Municipal Council v Harvey [1995] NSWSC 149; (1995) 86 LGERA 389 at 397 (NSW CA), per Kirby P. However, the boundaries of legitimate intervention are flexible and will be influenced by the need for intervention to ensure a fair and just trial: Panagopoulos v Southern Healthcare Network (unreported, Supreme Court, Vic, Smith J, 15 September 1997) at 6.'
316 The position can be stated no more clearly than reiterating that the judge must remain at all times the impartial adjudicator of the matter, measured against the touchstone of fairness."
(1) the disclosure of FZP's health information was reasonably necessary for the purposes of HPP 11 (HRIP Act, Sch 1); and
(2) that there was no use by SCHN of FZP's health information.
(1) The name of the Respondent is corrected from "Sydney Children's Hospital Network" to "Sydney Children's Hospitals Network".
(2) Leave to appeal is granted with respect to whether the Respondent's conduct constituted both a use and disclosure of FZP's health information.
(3) The appeal is allowed.
(4) The decision of the Tribunal that the disclosure of FZP's health information was reasonably necessary for the secondary purpose of research in accordance with HPP 11 of Schedule 1 to the Health Records and Information Privacy Act 2002 (NSW) is set aside.
(5) The decision of the Tribunal that there was no use of FZP's health information to which HPP 10 of Schedule 1 to the Health Records and Information Privacy Act 2002 (NSW) applied is set aside.
(6) The matter is remitted to the Tribunal, differently constituted, to redetermine, in accordance with these reasons.
(7) The decision of the Tribunal made on 18 June 2025 is otherwise affirmed.
(8) Pursuant to s 64(1)(a) of the Civil and Administrative Tribunal Act 2013 (NSW), publication or broadcast of the name of the Appellant is prohibited.
I hereby certify that this is a true and accurate record of the reasons for decision of the Civil and Administrative Tribunal of New South Wales.
FZP
Sydney Children's Hospitals Network [2026] NSWCATAP 55;
(1981) 150 CLR 1
(2019) 240 LGERA 387
(1995) 184 CLR 163
(2013) 85 NSWLR 378
(2008) 72 NSWLR 647
(2015) 233 FCR 315
(2011) 243 CLR 506
(1936) 55 CLR 499
(2019) 264 CLR 421
(2001) 206 CLR 323
(2022) 276 CLR 80
(2020) 103 NSWLR 36
(1989) 168 CLR 210
(2013) 85 NSWLR 240
(2017) 95 NSWLR 597
(1994) 53 FCR 287
(1979) 142 CLR 531
(2006) 228 CLR 423
(2007) 34 WAR 403
(1947) 74 CLR 492
(2007) 81 ALJR 1175
(1975) 132 CLR 473
(1987) 61 ALJR 393
(1990) 170 CLR 321
(1987) 9 NSWLR 154
(1906) 4 CLR 835
(1985) 4 NSWLR 139
(1990) 19 NSWLR 91
(2004) 63 IPR 54
(2005) 94 SASR 154
(1984) 3 NSWLR 168
(1999) 84 FCR 438
(1995) 86 LGERA 389